Results 251 to 260 of about 297,195 (347)
Surgical and molecular pathology of pancreatic neoplasms. [PDF]
Hackeng WM +3 more
europepmc +1 more source
Cystic masses of the pancreas : how useful is cyst fluid analysis in the diagnosis? [PDF]
Cesmeli, Ercan +5 more
core +1 more source
KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression
Cholangiocarcinoma (CCA) driven by oncogenic KRAS depends on its continuous activation for tumor maintenance. Using a conditional KRAS model, the authors show that turning off KRAS triggers rapid tumor regression accompanied by immune cell infiltration and cytokine release. The findings uncover a KRAS–senescence–immune signaling axis and highlight KRAS
Youwei Qiao +9 more
wiley +1 more source
This study presents a Kolmogorov–Arnold network (KAN)‐powered nanoplasmonic biosensing platform for ultrasensitive detection of small extracellular vesicles in serum, enabling highly accurate pancreatic cancer screening. The method achieves an area under the curve (AUC) of 0.99 in a large clinical cohort, offering a robust and interpretable deep ...
Jiaheng Zhu +21 more
wiley +1 more source
Pathological and molecular evaluation of pancreatic neoplasms. [PDF]
Rishi A, Goggins M, Wood LD, Hruban RH.
europepmc +1 more source
Laeverin is Cell‐Surface Target for Liquid‐Phase Metastasizing Cancer Cells
This study revealed that epithelial cancer cells in the floating phase induce the expression of laeverin (LVRN) that is a trophoblast‐specific and cell‐surface immunoregulatory factor and showed that anti‐LVRN ADC is a promising agent that can attack cancer cells in the metastatic liquid phase and block further distant metastasis.
Haruki Kasama +17 more
wiley +1 more source
Endoscopic ultrasound-guided therapies in pancreatic neoplasms. [PDF]
Yang D, DiMaio CJ.
europepmc +1 more source

